CVS Health currently offers a diverse set of healthcare services, although it plans to split into two organizations in early 2028. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 26 million medical members. The acquisition of Oak Street Health added primary care services to the mix.
Last trade$86.00
Day change-$2.5908 (-2.92%)
Day range$84.73 – $88.70
Volume8,126,093
Market cap$113.35B
OpenXNYS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$113.35B
Price / earnings
10.27×
Price / book
1.41×
Price / sales
0.27×
EV / sales
0.39×
EV / EBITDA
9.48×
Profitability
Earnings per share
$8.63
Return on assets
4.28%
Return on equity
13.71%
Dividend yield
3.02%
Liquidity and leverage
Debt / equity
0.75×
Current ratio
0.85×
Quick ratio
0.66×
Cash ratio
0.13×
Cash flow
Price / cash flow
6.06×
Price / free cash flow
7.28×
Free cash flow
$15.57B
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for CVS, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$107.75B
$105.46B
$99.85B
$105.1B
$102.24B
$98.43B
$94.07B
$96.96B
Cost of revenue
$93.5B
$90.35B
$84.8B
$92.13B
$89.07B
$85.32B
$80.19B
$84.81B
Gross profit
$14.25B
$15.11B
$15.05B
$12.97B
$13.17B
$13.11B
$13.88B
$12.14B
Selling, general and administrative
$0
$0
$0
$0
$0
$0
$0
$0
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$11.33B
$11.05B
$10.94B
$11.46B
$17.01B
$11.21B
$11.02B
$10.53B
Operating income
$2.92B
$4.06B
$4.11B
$1.52B
-$3.84B
$1.89B
$2.85B
$1.61B
Interest expense
-$747M
-$757M
-$774M
-$787M
-$784M
-$763M
-$785M
-$758M
Income before taxes
$2.85B
$3.98B
$3.94B
$1.35B
-$3.48B
$1.65B
$2.62B
$2.13B
Income taxes
$678M
$982M
$981M
-$1.57B
$508M
$634M
$835M
$503M
Net income
$2.17B
$3B
$2.96B
$2.92B
-$3.99B
$1.01B
$1.78B
$1.62B
Net income attributable to common shareholders
$2.17B
$2.98B
$2.94B
$2.94B
-$3.98B
$1.02B
$1.78B
$1.64B
EBITDA
$4.05B
$5.19B
$5.22B
$2.67B
$3.02B
$3.07B
$4.01B
$2.77B
Basic earnings per share
$1.70
$2.33
$2.31
$2.31
-$3.13
$0.81
$1.41
$1.30
Diluted earnings per share
$1.68
$2.31
$2.30
$2.30
-$3.13
$0.80
$1.41
$1.30
Recent news
Company coverage with links to the original publishers.
CVS Health is highlighted as a potential growth investment opportunity despite holding a #3 (Hold) Zacks Rank. The company demonstrates strong fundamentals with an A-rated VGM Score and Growth Style Score, forecasting 21.8% year-over-year earnings growth for the current fiscal year. Ten analysts have revised earnings estimates upward in the last 60 days, with the consensus estimate increasing to $8.22 per share and an average earnings surprise of +23.3%.
CVS Health announced plans to separate into two independent publicly traded companies: one retaining Aetna health insurance and Caremark pharmacy benefit manager, while CVS Pharmacy operates the retail store network. The company raised 2026 guidance, achieved target leverage ahead of schedule enabling share buyback resumption, and saw improved Medicare Advantage profitability through disciplined pricing and medical cost management.
UnitedHealth Group's Optum Rx segment increased operating earnings by 10.9% to $1.72 billion in Q3 2026 despite a 5.1% decline in adjusted prescriptions, driven by biosimilar adoption and operational efficiencies. However, membership losses and declining prescription volumes pose sustainability challenges for future growth. Specialty pharmacy volumes grew 2.6%, offering some offset to overall volume pressures.
CVS Health announced plans to separate into two independent publicly traded companies by mid-2028: one retaining Aetna, Caremark, and care operations, and another housing retail pharmacies and MinuteClinic. The split aims to improve capital allocation and operating flexibility, though it carries execution risks, restructuring costs, and potential dis-synergies during the transition period.
CVS Health has gained 1.7% over the past month, outperforming the S&P 500's -3.7% decline. The company is expected to report earnings of $1.11 per share for the current quarter with 21.6% year-over-year growth projected for the fiscal year. CVS recently beat consensus EPS estimates by 29.01% and revenue estimates by 3.2%, demonstrating a strong track record of outperformance. The stock has been assigned a Zacks Rank #2 (Buy) rating and is trading at a discount to peers with an A valuation grade.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Oct 22, 2026
$0.665
Nov 2, 2026
recurring
Jul 23, 2026
$0.665
Aug 3, 2026
recurring
Apr 23, 2026
$0.665
May 4, 2026
recurring
Jan 22, 2026
$0.665
Feb 2, 2026
recurring
Oct 23, 2025
$0.665
Nov 3, 2025
recurring
Stock splits
Historical share-structure events and their execution dates.